L. Newman, J. Rowley, and S. Vander-hoorn, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PLoS One, vol.10, p.14330, 2015.

, European Centre for Disease Prevention and Control. Surveillance report. Sexually transmitted infections in Europe, 2013.

, Reported STDs in the United States, CDC fact sheet, 2016.

R. M. Grant, J. R. Lama, and P. L. Anderson, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, N Engl J Med, vol.363, pp.2587-99, 2010.

S. Mccormack, D. Dunn, and M. Desai, Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial, Lancet, vol.387, pp.53-60, 2016.

J. M. Molina, C. Capitant, and B. Spire, on-demand preexposure prophylaxis in men at high risk for HIV-1 infection, N Engl J Med, vol.373, pp.2237-2283, 2015.
URL : https://hal.archives-ouvertes.fr/halshs-01429281

J. E. Volk, J. L. Marcus, and T. Phengrasamy, No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting, Clin Infect Dis, vol.61, pp.1601-1604, 2015.

A. Y. Liu, S. E. Cohen, and E. Vittinghoff, Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services, JAMA Intern Med, vol.176, pp.75-84, 2016.

J. L. Marcus, L. B. Hurley, and C. B. Hare, Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation, J Acquir Immune Defic Syndr, vol.73, pp.540-586, 2016.

K. Alaeia, C. A. Payntera, S. C. Juana, and A. Alaeia, Using preexposure prophylaxis, losing condoms? Preexposure prophylaxis promotion may undermine safe sex, AIDS, vol.30, pp.2753-56, 2016.

J. A. Loveless and W. Denton, The oral use of sulfathiazole as a prophylaxis for gonorrhea, JAMA, vol.121, pp.827-855, 1943.

H. Eagle, A. V. Gude, G. E. Beckmann, G. Mast, J. J. Sapero et al., Prevention of gonorrhea with penicillin tablets. preliminary report, Public Health Reports, vol.63, pp.1411-1426, 1948.

W. O. Harrison, R. R. Hooper, and P. J. Wiesner, A trial of minocycline given after exposure to prevent gonorrhea, N Engl J Med, vol.300, pp.1074-78, 1979.

R. Kaul, J. Kimani, and N. J. Nagelkerke, Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial, JAMA, vol.291, pp.2555-62, 2004.

R. Steen, M. Chersich, and A. Gerbase, Periodic presumptive treatment of curable sexually transmitted infections among sex workers: a systematic review, AIDS, vol.26, pp.437-482, 2012.

M. Unemo and W. M. Shafer, Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future, Clin Microbiol Rev, vol.27, pp.587-613, 2014.

N. Borel, C. Leonard, J. Slade, and R. V. Schoborg, Chlamydial antibiotic resistance and treatment failure in veterinary and human medicine, Curr Clin Microbiol Rep, vol.3, pp.10-18, 2016.

L. V. Stamm, Global challenge of antibiotic-resistant Treponema pallidum, Antimicrob Agents Chemother, vol.54, pp.583-89, 2010.

R. B. Nadelman, J. Nowakowski, and D. Fish, Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite, N Engl J Med, vol.345, pp.79-84, 2001.

E. T. Takafuji, J. W. Kirkpatrick, and R. N. Miller, An efficacy trial of doxycycline chemoprophylaxis against leptospirosis, N Engl J Med, vol.310, pp.497-500, 1984.

R. K. Bolan, M. R. Beymer, R. E. Weiss, R. P. Flynn, A. A. Leibowitz et al., Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study, Sex Transm Dis, vol.42, pp.98-103, 2015.

J. M. Molina, I. Charreau, and B. Spire, Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study, Lancet HIV, vol.4, pp.402-412, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01963237

P. Rodriguez, A. Vekris, B. De-barbeyrac, B. Dutilh, J. Bonnet et al., Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene, J Clin Microbiol, vol.29, pp.1132-1168, 1991.

K. A. Workowski and G. A. Bolan, Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep, vol.64, pp.1-137, 2015.

. Anrs, ANRS scale to grade the severity of adverse events in adults. Version number 6, Sept, vol.9, 2003.

L. Ruche, G. Goubard, A. Bercot, B. Cambau, E. Semaille et al., Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, Euro Surveill, vol.19, p.20885, 2001.

R. D. Kirkcaldy, A. Harvey, and J. R. Papp, Neisseria gonorrhoeae antimicrobial susceptibility surveillance-the gonococcal isolate surveillance project, 27 Sites, MMWR Surveill Summ, vol.65, pp.1-19, 2014.
DOI : 10.15585/mmwr.ss6507a1
URL : https://www.cdc.gov/mmwr/volumes/65/ss/pdfs/ss6507.pdf

S. Saivin and G. Houin, Clinical pharmacokinetics of doxycycline and minocycline, Clin Pharmacokinet, vol.15, pp.355-66, 1988.

M. J. Wawer, N. K. Sewankambo, and D. Serwadda, Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group, Lancet, vol.353, pp.525-560, 1999.

S. L. Gottlieb and C. Johnston, Future prospects for new vaccines against sexually transmitted infections, Curr Opin Infect Dis, vol.30, pp.77-86, 2017.
DOI : 10.1097/qco.0000000000000343
URL : http://europepmc.org/articles/pmc5325242?pdf=render